These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22868173)

  • 1. Directing reprogramming to pluripotency by transcription factors.
    Adachi K; Schöler HR
    Curr Opin Genet Dev; 2012 Oct; 22(5):416-22. PubMed ID: 22868173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors.
    Kim JB; Zaehres H; Wu G; Gentile L; Ko K; Sebastiano V; Araúzo-Bravo MJ; Ruau D; Han DW; Zenke M; Schöler HR
    Nature; 2008 Jul; 454(7204):646-50. PubMed ID: 18594515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The magic of four: induction of pluripotent stem cells from somatic cells by Oct4, Sox2, Myc and Klf4.
    Qi H; Pei D
    Cell Res; 2007 Jul; 17(7):578-80. PubMed ID: 17632550
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More synergetic cooperation of Yamanaka factors in induced pluripotent stem cells than in embryonic stem cells.
    Huang J; Chen T; Liu X; Jiang J; Li J; Li D; Liu XS; Li W; Kang J; Pei G
    Cell Res; 2009 Oct; 19(10):1127-38. PubMed ID: 19736564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression Nanog activates pluripotent genes in porcine fetal fibroblasts and nuclear transfer embryos.
    Zhang L; Luo YB; Bou G; Kong QR; Huan YJ; Zhu J; Wang JY; Li H; Wang F; Shi YQ; Wei YC; Liu ZH
    Anat Rec (Hoboken); 2011 Nov; 294(11):1809-17. PubMed ID: 21972213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells.
    Liu X; Huang J; Chen T; Wang Y; Xin S; Li J; Pei G; Kang J
    Cell Res; 2008 Dec; 18(12):1177-89. PubMed ID: 19030024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klf4 interacts directly with Oct4 and Sox2 to promote reprogramming.
    Wei Z; Yang Y; Zhang P; Andrianakos R; Hasegawa K; Lyu J; Chen X; Bai G; Liu C; Pera M; Lu W
    Stem Cells; 2009 Dec; 27(12):2969-78. PubMed ID: 19816951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endogenous KLF4 expression in human fetal endothelial cells allows for reprogramming to pluripotency with just OCT3/4 and SOX2--brief report.
    Ho PJ; Yen ML; Lin JD; Chen LS; Hu HI; Yeh CK; Peng CY; Lin CY; Yet SF; Yen BL
    Arterioscler Thromb Vasc Biol; 2010 Oct; 30(10):1905-7. PubMed ID: 20689077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
    Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
    Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induced pluripotency with endogenous and inducible genes.
    Duinsbergen D; Eriksson M; 't Hoen PA; Frisén J; Mikkers H
    Exp Cell Res; 2008 Oct; 314(17):3255-63. PubMed ID: 18656469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional Control of Somatic Cell Reprogramming.
    Xu Y; Zhang M; Li W; Zhu X; Bao X; Qin B; Hutchins AP; Esteban MA
    Trends Cell Biol; 2016 Apr; 26(4):272-288. PubMed ID: 26776886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of pluripotency-associated genes in mouse embryonic fibroblasts by non-viral transfection with in vitro-derived mRNAs encoding Oct4, Sox2, Klf4 and cMyc.
    Tavernier G; Wolfrum K; Demeester J; De Smedt SC; Adjaye J; Rejman J
    Biomaterials; 2012 Jan; 33(2):412-7. PubMed ID: 21993235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of clinically relevant "induced pluripotent stem" (iPS) cells.
    Heffernan C; Sumer H; Verma PJ
    J Stem Cells; 2011; 6(3):109-27. PubMed ID: 23264997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H3K4 Methyltransferase Set1a Is A Key Oct4 Coactivator Essential for Generation of Oct4 Positive Inner Cell Mass.
    Fang L; Zhang J; Zhang H; Yang X; Jin X; Zhang L; Skalnik DG; Jin Y; Zhang Y; Huang X; Li J; Wong J
    Stem Cells; 2016 Mar; 34(3):565-80. PubMed ID: 26785054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem cells. A new year and a new era.
    Pera MF
    Nature; 2008 Jan; 451(7175):135-6. PubMed ID: 18185576
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction of pluripotency: from mouse to human.
    Zaehres H; Schöler HR
    Cell; 2007 Nov; 131(5):834-5. PubMed ID: 18045526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging methods for preparing iPS cells.
    Miyazaki S; Yamamoto H; Miyoshi N; Takahashi H; Suzuki Y; Haraguchi N; Ishii H; Doki Y; Mori M
    Jpn J Clin Oncol; 2012 Sep; 42(9):773-9. PubMed ID: 22826352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landmark approach to generating human stem cells.
    Daubman S
    Circ Res; 2011 Jan; 108(2):161-3. PubMed ID: 21252149
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct reprogramming 101.
    Takahashi K
    Dev Growth Differ; 2010 Apr; 52(3):319-33. PubMed ID: 20298260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.